Chart 4. Advantages and disadvantages of using biomarkers in infectious diseases.
| Advantages |
|---|
| Provide information that is specific to infections requiring antibiotics |
| High levels in bacterial infections and low levels in viral infections |
| Levels increase rapidly in bacterial infections |
| Response does not depend on the organism |
| Levels may be altered at disease onset, before clinical and radiological abnormalities |
| May help define prognosis |
| Improve the yield of severity scores |
| Help monitor therapeutic response |
| May be more specific than clinical manifestations |
| May help reduce antibiotic use without adverse consequences |
| Disadvantages |
| Results may conflict with careful clinical assessment |
| Previous use of antibiotics may rapidly reduce levels and lead to false-negative findings |
| May not differentiate between pneumonia caused by atypical pathogens and viral pneumonia |
| Do not always recognize influenza complicated by bacterial infection |
| Do not distinguish between chemical aspiration pneumonia and secondary bacterial aspiration pneumonia |
Adapted from Müller et al. 52